- Email: [email protected]
Guide to Authors
Advanced Drug Delivery Reviews 54 (2002) 883–885 www.elsevier.com / locate / drugdeliv
Guide to Authors Theme issues are generally commissioned by one of the Executive Editors or the Editor-in-Chief. If you wish to submit a theme issue topic for consideration, please contact one of the editors. Submission of Manuscripts Firstly, any manuscript is accepted on the understanding that it is not under consideration for publication elsewhere, that all the named authors have agreed to its submission and that, if accepted, it will not be published again in the same form, in any language, without the consent of the Publishers. For the initial submission, the original manuscript plus three copies, complete with figures (including originals or duplicates of sufficient quality for clarity of reproduction) and tables, should be submitted to the Theme Issue editor so as to facilitate refereeing. A disk is not required in preliminary stages of refereeing, but it is absolutely necessary once the final version of the article is accepted for publication. Please include full contact information – corresponding author name, e-mail address, telephone and fax numbers, and full postal address. After final acceptance for publication, your revised manuscript on disk together with two printed hard copies, should be submitted to the Theme Issue editor. It is important that the file on disk and the printout are identical. See ‘Electronic manuscripts’ below. Editor-in-Chief ]]]] Professor V.H.L. Lee Department of Pharmaceutical Sciences, University of Southern California, School of Pharmacy, 1985 Zonal Avenue, PSC 704, Los Angeles, CA 90089-9121 USA Tel: 1 1-323-442-1368; Fax: 1 1-323-442-1390; E-mail: [email protected] Executive Editors ]]]]] Biological Principles of Drug Delivery Professor K.L.R. Brouwer Division of Drug Delivery and Disposition, School of Pharmacy, C.B. [7360 Beard Hall, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7360 USA Tel: 1 1-919-962-7030; Fax: 1 1-919-966-0197; E-mail: [email protected] Engineering & Technology of Drug Delivery Professor K. Kataoka Department of Materials Science, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656 Japan Tel: 1 81-3-5841-7138; Fax: 1 81-3-5841-7139; E-mail: [email protected] Physicochemical Principles of Drug Delivery Professor T. Kissel Philipps University Marburg Department of Pharmaceutics & Biopharmacy, Ketzerbach 63, D-35037 Marburg Germany Tel: 1 49-6421-282-5881; Fax: 1 49-6421-282-7016; E-mail: [email protected]
PII: S0169-409X( 02 )00105-9
884
Guide to Authors
Therapeutical Applications of Drug Delivery Dr. P.L. Smith S.R. One, Limited, WY 1000, Four Tower Bridge, 200 Barr Harbor Drive, Suite 250, W. Conshohocken, PA 19428-2977 USA, Tel: 1 1-610-567-1001, Fax: 1 1-610-567-1039, E-mail: [email protected] Electronic Manuscripts Electronic manuscripts have the advantage that there is no need for the rekeying of text, thereby avoiding the possibility of introducing errors and resulting in reliable and fast delivery of proofs. The preferred storage medium is a 3.5 inch disk or a ZIP disk in PC format, although Macintosh format is also welcome (in this case, save your file in the usual manner, do not use the option save in MS-DOS format). Please do not split the manuscript into separate files (title page as one file, text as another, etc.) Ensure that the letter ‘I’ and digit ‘1’ (also letter ‘0’ and digit ‘0’) have been used properly, and format your article (tabs, indents, etc.) consistently. Characters not available on your word processor (Greek letters, mathematical symbols, etc.) should not be left open but indicated by a unique code (e.g, gralpha, @, [, etc., for the Greek Letter a). Such codes should be used consistently throughout the entire text. Please make a list of such codes and provide a key. Do not allow your word processor to introduce word splits and do not use a ‘justified’ layout. Please adhere strictly to the general instructions on style / arrangement and, in particular, the reference style of the journal. It is very important that you save your file in the word processor format. If your word processor features the option to save files ‘in flat ASCII’, please do not use it. Format your disk correctly and ensure that only the relevant file (one complete article only) is on the disk. Also, specify the type of computer and word processing package used, label the disk with your name and the name of the file on the disk. Additional instructions on how to prepare your manuscript can be found at: http: / / authors.elsevier.com. More in-depth guidelines for submitting artwork / illustrations can be found at: http: / / authors.elsevier.com / artwork. Presentation of Manuscripts Papers should be written in English. There are no page charges. An author checklist can be found at: http: / / authors.elsevier.com / quickguide Papers should conform to the following guidelines: 1. Articles should be typewritten or printed in (near) letter quality, on one side of the sheet, double- spaced (also references and figure legends), with a wide margin down the left-hand side of the paper. 2. The full postal address of the author(s), including postal code and country, should be given after the authors’ names. An indication should be made of one author to whom proofs should be sent. Please give e-mail address, telephone and fax numbers. 3. An abstract of usually less than 150 words should be supplied. This summary should state the objective, findings and conclusions of the work reviewed. 4. Key words. A list of 6 to 10 words or short phrases (not already used in the title) should be included on the first page. These terms will be printed after the abstract. 5. General arrangements of papers: (A) reviews should be divided into sections, each headed by a caption (abstract, introduction, review-specific subtitles, conclusions, references); (B) the sections should be numbered 1,1.1, 1.1.1 etc. for major sections and subsections, respectively. A table of contents specifying the sections and subsections should be supplied. 6. Line-drawn figures should be black ink on white paper and must be lettered ready for direct reproduction. A high-resolution computer print-out is also acceptable. Alternatively, sharp photoprints of lettered line-drawings may be submitted. Lettering should not be smaller than 1.5 mm after reduction. Bear in mind that the page size is 16x20 cm. 7. Half-tone figures should be submitted as sharp, glossy prints, preferably needing no reduction and with a bar indicating unit length. 8. Legends for both line-drawings and half-tone prints must be typed / printed, double- spaced, on a separate sheet. The first sentence of the legend should constitute a concise title for the figure. 9. Nomenclature and abbreviations. Where possible, nomenclature and abbreviations should be used in accordance with internationally agreed rules. Only standard abbreviations should be used. Chemical and biochemical abbreviations should be in accordance with the recommendation of the IUPAC-IUB Combined Commission on Biochemical Nomenclature. Unfamiliar acronyms are not encouraged and no acronyms should appear in the abstract or title. This information may be found in Biochemical Nomenclature and Related Documents published by the Biochemical Society (London) for the IUB. Where specialised abbreviations are used in the body of the paper, the name should be given in full in the first instance with the abbreviation indicated in parentheses.
Guide to Authors
885
10. References should be cited in the text by number, in line with the rest of the text, in square brackets; for example, ‘according to Smith and Jones [3]’. The numbering of the typed list of references should be in order of citation in the text, not in alphabetical order. References to journals should contain the names and initials of all the authors, year of publication in parentheses, the title of the paper and the abbreviation of the title of the journal according to the List of Serial Title World Abbreviations (International Serials Data System, 20 rue Bachaumont, 75002 Paris, France. ISBN 2-904939-02-8). These should be followed by the volume number and first and last page numbers. Reference to a paper as ‘‘in press’’ implies that it has been accepted for publication. Personal communications and unpublished results should not appear in the list of references. References to books should include the title of the book, the publishing company and year of publication. For further details see reference lists in a current issue of the journal. Examples of journals in the typed list of references: N.B. The brackets around reference numbers in the reference list itself are generated automatically. [1] F. Ziang, Y. Lin, J. Wen, D.W. Matson, R.D. Smith, An integrated microfabricated device for dual microdialysis and on-line ESI-ion trap mass spectrometry for analysis of complex biological samples, Anal. Chem. 71 (1999) 1485–1490. [2] H.C. Korting. Preface. The skin as a site for drug delivery: the liposome approach and its alternatives. Adv. Drug Deliv. Rev. 18 (1996) 271 –272. ¨ [3] C. Anderson, C. Svensson, F. Sjogren, T. Andersson, K. Wardell, Human in vivo microdialysis can be used to measure cytokines in contact reactions, in: P. EIsner, H.I. Maibach (Eds.), Current Problems in Dermatology, Vol. 23, Karger, Basel, 1995, pp. 121–130. [4] V. Claassen, Anaesthesia, in: J.P. Huston (Ed.), Techniques in the Behavioral and Neural Sciences, Neglected Factors in Pharmacology and Neuroscience Research, Vol. 12, Elsevier Science B.V., Amsterdam, 1994, pp. 25–35. 11. Advanced Drug Delivery Reviews has no page charges. The 2002 price for color figures is EUR 272 / US$ 312 for the first page and EUR 182 / US$ 208 for subsequent pages. 12. Proofs. Elsevier Science is now sending PDF proofs to authors by e-mail for correction. If an author is unable to handle this process, regular print proofs will be sent. Elsevier Science will do everything possible to get the article corrected and published as quickly and accurately as possible. Therefore, it is important to ensure that all corrections are sent back in ONE communication. Subsequent corrections will not be possible. Only typesetting errors may be corrected; no changes in, or additions to, the accepted manuscript will be allowed. Proofs should be returned to Elsevier Science within 48 hours. 13. Reprints and copyright. After acceptance of the paper the author will receive an order form with which reprints can be ordered in excess of the 25 free reprints allowed. A form transferring copyright will also be provided. It is essential that copyright be transferred to the publisher at this stage. This transfer will ensure the widest dissemination of information. 14. Author enquiries. All questions arising after acceptance of a manuscript by the Editor, especially those relating to proofs, publication, and reprints, should be directed to the Publisher. Elsevier Science Ireland Ltd. Brookvale Plaza East Park Shannon, Co. Clare Ireland Tel: 1 353-61-709600 Fax: 1 353-61-709100 E-mail: [email protected] Please visit the Elsevier Science Author Gateway at http: / / authors.elsevier.com to track accepted articles and set up e-mail alerts to inform you of when the article status has changed. Information on artwork guidelines, copyright information, and frequently asked questions is also available.
Guide to Authors Theme issues are generally commissioned by one of the Executive Editors or the Editor-in-Chief. If you wish to submit a theme issue topic for consideration, please contact one of the editors. Submission of Manuscripts Firstly, any manuscript is accepted on the understanding that it is not under consideration for publication elsewhere, that all the named authors have agreed to its submission and that, if accepted, it will not be published again in the same form, in any language, without the consent of the Publishers. For the initial submission, the original manuscript plus three copies, complete with figures (including originals or duplicates of sufficient quality for clarity of reproduction) and tables, should be submitted to the Theme Issue editor so as to facilitate refereeing. A disk is not required in preliminary stages of refereeing, but it is absolutely necessary once the final version of the article is accepted for publication. Please include full contact information – corresponding author name, e-mail address, telephone and fax numbers, and full postal address. After final acceptance for publication, your revised manuscript on disk together with two printed hard copies, should be submitted to the Theme Issue editor. It is important that the file on disk and the printout are identical. See ‘Electronic manuscripts’ below. Editor-in-Chief ]]]] Professor V.H.L. Lee Department of Pharmaceutical Sciences, University of Southern California, School of Pharmacy, 1985 Zonal Avenue, PSC 704, Los Angeles, CA 90089-9121 USA Tel: 1 1-323-442-1368; Fax: 1 1-323-442-1390; E-mail: [email protected] Executive Editors ]]]]] Biological Principles of Drug Delivery Professor K.L.R. Brouwer Division of Drug Delivery and Disposition, School of Pharmacy, C.B. [7360 Beard Hall, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7360 USA Tel: 1 1-919-962-7030; Fax: 1 1-919-966-0197; E-mail: [email protected] Engineering & Technology of Drug Delivery Professor K. Kataoka Department of Materials Science, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656 Japan Tel: 1 81-3-5841-7138; Fax: 1 81-3-5841-7139; E-mail: [email protected] Physicochemical Principles of Drug Delivery Professor T. Kissel Philipps University Marburg Department of Pharmaceutics & Biopharmacy, Ketzerbach 63, D-35037 Marburg Germany Tel: 1 49-6421-282-5881; Fax: 1 49-6421-282-7016; E-mail: [email protected]
PII: S0169-409X( 02 )00105-9
884
Guide to Authors
Therapeutical Applications of Drug Delivery Dr. P.L. Smith S.R. One, Limited, WY 1000, Four Tower Bridge, 200 Barr Harbor Drive, Suite 250, W. Conshohocken, PA 19428-2977 USA, Tel: 1 1-610-567-1001, Fax: 1 1-610-567-1039, E-mail: [email protected] Electronic Manuscripts Electronic manuscripts have the advantage that there is no need for the rekeying of text, thereby avoiding the possibility of introducing errors and resulting in reliable and fast delivery of proofs. The preferred storage medium is a 3.5 inch disk or a ZIP disk in PC format, although Macintosh format is also welcome (in this case, save your file in the usual manner, do not use the option save in MS-DOS format). Please do not split the manuscript into separate files (title page as one file, text as another, etc.) Ensure that the letter ‘I’ and digit ‘1’ (also letter ‘0’ and digit ‘0’) have been used properly, and format your article (tabs, indents, etc.) consistently. Characters not available on your word processor (Greek letters, mathematical symbols, etc.) should not be left open but indicated by a unique code (e.g, gralpha, @, [, etc., for the Greek Letter a). Such codes should be used consistently throughout the entire text. Please make a list of such codes and provide a key. Do not allow your word processor to introduce word splits and do not use a ‘justified’ layout. Please adhere strictly to the general instructions on style / arrangement and, in particular, the reference style of the journal. It is very important that you save your file in the word processor format. If your word processor features the option to save files ‘in flat ASCII’, please do not use it. Format your disk correctly and ensure that only the relevant file (one complete article only) is on the disk. Also, specify the type of computer and word processing package used, label the disk with your name and the name of the file on the disk. Additional instructions on how to prepare your manuscript can be found at: http: / / authors.elsevier.com. More in-depth guidelines for submitting artwork / illustrations can be found at: http: / / authors.elsevier.com / artwork. Presentation of Manuscripts Papers should be written in English. There are no page charges. An author checklist can be found at: http: / / authors.elsevier.com / quickguide Papers should conform to the following guidelines: 1. Articles should be typewritten or printed in (near) letter quality, on one side of the sheet, double- spaced (also references and figure legends), with a wide margin down the left-hand side of the paper. 2. The full postal address of the author(s), including postal code and country, should be given after the authors’ names. An indication should be made of one author to whom proofs should be sent. Please give e-mail address, telephone and fax numbers. 3. An abstract of usually less than 150 words should be supplied. This summary should state the objective, findings and conclusions of the work reviewed. 4. Key words. A list of 6 to 10 words or short phrases (not already used in the title) should be included on the first page. These terms will be printed after the abstract. 5. General arrangements of papers: (A) reviews should be divided into sections, each headed by a caption (abstract, introduction, review-specific subtitles, conclusions, references); (B) the sections should be numbered 1,1.1, 1.1.1 etc. for major sections and subsections, respectively. A table of contents specifying the sections and subsections should be supplied. 6. Line-drawn figures should be black ink on white paper and must be lettered ready for direct reproduction. A high-resolution computer print-out is also acceptable. Alternatively, sharp photoprints of lettered line-drawings may be submitted. Lettering should not be smaller than 1.5 mm after reduction. Bear in mind that the page size is 16x20 cm. 7. Half-tone figures should be submitted as sharp, glossy prints, preferably needing no reduction and with a bar indicating unit length. 8. Legends for both line-drawings and half-tone prints must be typed / printed, double- spaced, on a separate sheet. The first sentence of the legend should constitute a concise title for the figure. 9. Nomenclature and abbreviations. Where possible, nomenclature and abbreviations should be used in accordance with internationally agreed rules. Only standard abbreviations should be used. Chemical and biochemical abbreviations should be in accordance with the recommendation of the IUPAC-IUB Combined Commission on Biochemical Nomenclature. Unfamiliar acronyms are not encouraged and no acronyms should appear in the abstract or title. This information may be found in Biochemical Nomenclature and Related Documents published by the Biochemical Society (London) for the IUB. Where specialised abbreviations are used in the body of the paper, the name should be given in full in the first instance with the abbreviation indicated in parentheses.
Guide to Authors
885
10. References should be cited in the text by number, in line with the rest of the text, in square brackets; for example, ‘according to Smith and Jones [3]’. The numbering of the typed list of references should be in order of citation in the text, not in alphabetical order. References to journals should contain the names and initials of all the authors, year of publication in parentheses, the title of the paper and the abbreviation of the title of the journal according to the List of Serial Title World Abbreviations (International Serials Data System, 20 rue Bachaumont, 75002 Paris, France. ISBN 2-904939-02-8). These should be followed by the volume number and first and last page numbers. Reference to a paper as ‘‘in press’’ implies that it has been accepted for publication. Personal communications and unpublished results should not appear in the list of references. References to books should include the title of the book, the publishing company and year of publication. For further details see reference lists in a current issue of the journal. Examples of journals in the typed list of references: N.B. The brackets around reference numbers in the reference list itself are generated automatically. [1] F. Ziang, Y. Lin, J. Wen, D.W. Matson, R.D. Smith, An integrated microfabricated device for dual microdialysis and on-line ESI-ion trap mass spectrometry for analysis of complex biological samples, Anal. Chem. 71 (1999) 1485–1490. [2] H.C. Korting. Preface. The skin as a site for drug delivery: the liposome approach and its alternatives. Adv. Drug Deliv. Rev. 18 (1996) 271 –272. ¨ [3] C. Anderson, C. Svensson, F. Sjogren, T. Andersson, K. Wardell, Human in vivo microdialysis can be used to measure cytokines in contact reactions, in: P. EIsner, H.I. Maibach (Eds.), Current Problems in Dermatology, Vol. 23, Karger, Basel, 1995, pp. 121–130. [4] V. Claassen, Anaesthesia, in: J.P. Huston (Ed.), Techniques in the Behavioral and Neural Sciences, Neglected Factors in Pharmacology and Neuroscience Research, Vol. 12, Elsevier Science B.V., Amsterdam, 1994, pp. 25–35. 11. Advanced Drug Delivery Reviews has no page charges. The 2002 price for color figures is EUR 272 / US$ 312 for the first page and EUR 182 / US$ 208 for subsequent pages. 12. Proofs. Elsevier Science is now sending PDF proofs to authors by e-mail for correction. If an author is unable to handle this process, regular print proofs will be sent. Elsevier Science will do everything possible to get the article corrected and published as quickly and accurately as possible. Therefore, it is important to ensure that all corrections are sent back in ONE communication. Subsequent corrections will not be possible. Only typesetting errors may be corrected; no changes in, or additions to, the accepted manuscript will be allowed. Proofs should be returned to Elsevier Science within 48 hours. 13. Reprints and copyright. After acceptance of the paper the author will receive an order form with which reprints can be ordered in excess of the 25 free reprints allowed. A form transferring copyright will also be provided. It is essential that copyright be transferred to the publisher at this stage. This transfer will ensure the widest dissemination of information. 14. Author enquiries. All questions arising after acceptance of a manuscript by the Editor, especially those relating to proofs, publication, and reprints, should be directed to the Publisher. Elsevier Science Ireland Ltd. Brookvale Plaza East Park Shannon, Co. Clare Ireland Tel: 1 353-61-709600 Fax: 1 353-61-709100 E-mail: [email protected] Please visit the Elsevier Science Author Gateway at http: / / authors.elsevier.com to track accepted articles and set up e-mail alerts to inform you of when the article status has changed. Information on artwork guidelines, copyright information, and frequently asked questions is also available.